Total Payments
$49,569
2024 Payments
$12,668
Companies
10
Transactions
80
Medicare Patients
4,126
Medicare Billing
$199,527
Payment Breakdown by Category
Other$21,421 (43.2%)
Consulting$20,843 (42.0%)
Travel$5,949 (12.0%)
Food & Beverage$1,354 (2.7%)
Education$2.45 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $20,843 | 9 | 42.0% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $11,534 | 9 | 23.3% |
| Honoraria | $9,888 | 3 | 19.9% |
| Travel and Lodging | $5,949 | 26 | 12.0% |
| Food and Beverage | $1,354 | 32 | 2.7% |
| Education | $2.45 | 1 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| EUSA Pharma (US) LLC | $18,683 | 44 | $0 (2022) |
| RECORDATI_RARE_DISEASES_INC. | $12,668 | 9 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $8,532 | 14 | $0 (2019) |
| Acceleron Pharma, Inc. | $5,490 | 1 | $0 (2020) |
| Janssen Scientific Affairs, LLC | $2,712 | 6 | $0 (2017) |
| GENZYME CORPORATION | $570.00 | 2 | $0 (2018) |
| Becton, Dickinson and Company | $475.00 | 1 | $0 (2017) |
| Cepheid | $315.00 | 1 | $0 (2020) |
| United Therapeutics Corporation | $100.00 | 1 | $0 (2018) |
| Genentech USA, Inc. | $25.00 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $12,668 | 9 | RECORDATI_RARE_DISEASES_INC. ($12,668) |
| 2023 | $25.00 | 1 | Genentech USA, Inc. ($25.00) |
| 2022 | $1,275 | 1 | EUSA Pharma (US) LLC ($1,275) |
| 2021 | $540.00 | 1 | EUSA Pharma (US) LLC ($540.00) |
| 2020 | $5,805 | 2 | Acceleron Pharma, Inc. ($5,490) |
| 2019 | $17,183 | 44 | EUSA Pharma (US) LLC ($16,868) |
| 2018 | $3,253 | 4 | E.R. Squibb & Sons, L.L.C. ($3,033) |
| 2017 | $8,821 | 18 | E.R. Squibb & Sons, L.L.C. ($5,184) |
All Payment Transactions
80 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 08/31/2024 | RECORDATI_RARE_DISEASES_INC. | SYLVANT (Drug) | Honoraria | Cash or cash equivalent | $2,542.50 | General |
| Category: ONCOLOGIC AGENT | ||||||
| 08/31/2024 | RECORDATI_RARE_DISEASES_INC. | SYLVANT (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $325.00 | General |
| Category: ONCOLOGIC AGENT | ||||||
| 08/08/2024 | RECORDATI_RARE_DISEASES_INC. | SYLVANT (Drug) | Travel and Lodging | Cash or cash equivalent | $349.94 | General |
| Category: ONCOLOGIC AGENT | ||||||
| 06/26/2024 | RECORDATI_RARE_DISEASES_INC. | SYLVANT (Drug) | Honoraria | Cash or cash equivalent | $4,802.50 | General |
| Category: ONCOLOGIC AGENT | ||||||
| 06/26/2024 | RECORDATI_RARE_DISEASES_INC. | SYLVANT (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $526.70 | General |
| Category: ONCOLOGIC AGENT | ||||||
| 06/26/2024 | RECORDATI_RARE_DISEASES_INC. | SYLVANT (Drug) | Travel and Lodging | Cash or cash equivalent | $489.20 | General |
| Category: ONCOLOGIC AGENT | ||||||
| 02/26/2024 | RECORDATI_RARE_DISEASES_INC. | SYLVANT (Drug) | Honoraria | Cash or cash equivalent | $2,542.50 | General |
| Category: ONCOLOGIC AGENT | ||||||
| 02/26/2024 | RECORDATI_RARE_DISEASES_INC. | SYLVANT (Drug) | Travel and Lodging | Cash or cash equivalent | $617.14 | General |
| Category: ONCOLOGIC AGENT | ||||||
| 02/26/2024 | RECORDATI_RARE_DISEASES_INC. | SYLVANT (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $472.03 | General |
| Category: ONCOLOGIC AGENT | ||||||
| 09/12/2023 | Genentech USA, Inc. | — | Consulting Fee | Cash or cash equivalent | $25.00 | General |
| 01/31/2022 | EUSA Pharma (US) LLC | Sylvant (Drug) | Consulting Fee | Cash or cash equivalent | $1,275.00 | General |
| Category: Hematology | ||||||
| 06/30/2021 | EUSA Pharma (US) LLC | Sylvant (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $540.00 | General |
| Category: Hematology | ||||||
| 11/04/2020 | Acceleron Pharma, Inc. | Reblozyl (Drug) | Consulting Fee | Cash or cash equivalent | $5,490.00 | General |
| Category: Hematology | ||||||
| 04/14/2020 | Cepheid | GENEXPERT (Device) | Consulting Fee | Cash or cash equivalent | $315.00 | General |
| Category: MOLECULAR DIAGNOSTICS | ||||||
| 11/18/2019 | EUSA Pharma (US) LLC | Sylvant (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,500.00 | General |
| Category: Hematology Oncology | ||||||
| 11/18/2019 | EUSA Pharma (US) LLC | Sylvant (Biological) | Travel and Lodging | In-kind items and services | $25.57 | General |
| Category: Hematology Oncology | ||||||
| 11/18/2019 | EUSA Pharma (US) LLC | Sylvant (Biological) | Travel and Lodging | In-kind items and services | $23.47 | General |
| Category: Hematology Oncology | ||||||
| 11/18/2019 | EUSA Pharma (US) LLC | Sylvant (Biological) | Food and Beverage | Cash or cash equivalent | $23.35 | General |
| Category: Hematology Oncology | ||||||
| 11/18/2019 | EUSA Pharma (US) LLC | Sylvant (Biological) | Travel and Lodging | In-kind items and services | $22.97 | General |
| Category: Hematology Oncology | ||||||
| 11/18/2019 | EUSA Pharma (US) LLC | Sylvant (Biological) | Travel and Lodging | In-kind items and services | $22.35 | General |
| Category: Hematology Oncology | ||||||
| 11/18/2019 | EUSA Pharma (US) LLC | Sylvant (Biological) | Food and Beverage | Cash or cash equivalent | $14.17 | General |
| Category: Hematology Oncology | ||||||
| 11/18/2019 | EUSA Pharma (US) LLC | Sylvant (Biological) | Food and Beverage | Cash or cash equivalent | $11.53 | General |
| Category: Hematology Oncology | ||||||
| 11/18/2019 | EUSA Pharma (US) LLC | Sylvant (Biological) | Food and Beverage | Cash or cash equivalent | $9.42 | General |
| Category: Hematology Oncology | ||||||
| 11/18/2019 | EUSA Pharma (US) LLC | Sylvant (Biological) | Food and Beverage | Cash or cash equivalent | $7.39 | General |
| Category: Hematology Oncology | ||||||
| 11/18/2019 | EUSA Pharma (US) LLC | Sylvant (Biological) | Food and Beverage | Cash or cash equivalent | $5.63 | General |
| Category: Hematology Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 13 | 904 | 1,619 | $267,450 | $42,396 |
| 2022 | 13 | 1,143 | 2,018 | $330,886 | $54,095 |
| 2021 | 14 | 1,038 | 1,820 | $306,283 | $51,733 |
| 2020 | 13 | 1,041 | 1,849 | $291,096 | $51,302 |
Total Patients
4,126
Total Services
7,306
Medicare Billing
$199,527
Procedure Codes
53
All Medicare Procedures & Services
53 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 88341 | Special stained specimen slides to examine tissue, each additional procedure | Facility | 2023 | 78 | 448 | $40,320 | $9,735 | 24.1% |
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Facility | 2023 | 120 | 253 | $44,275 | $7,112 | 16.1% |
| 88360 | Microscopic genetic analysis of tumor, manual | Facility | 2023 | 95 | 205 | $46,125 | $6,411 | 13.9% |
| 88189 | Flow cytometry technique for dna or cell analysis, 16 or more markers | Facility | 2023 | 57 | 63 | $29,295 | $4,147 | 14.2% |
| 85097 | Bone marrow, smear interpretation | Facility | 2023 | 98 | 109 | $31,392 | $3,982 | 12.7% |
| 88342 | Special stained specimen slides to examine tissue, initial procedure | Facility | 2023 | 99 | 116 | $22,620 | $3,114 | 13.8% |
| 88365 | Genetic sequencing localization, initial procedure | Facility | 2023 | 62 | 67 | $18,090 | $2,206 | 12.2% |
| 88364 | Genetic sequencing localization, each additional procedure | Facility | 2023 | 47 | 55 | $8,250 | $1,379 | 16.7% |
| 88311 | Preparation of tissue for examination by removing any calcium present | Facility | 2023 | 105 | 118 | $6,490 | $1,096 | 16.9% |
| 88313 | Special stained specimen slides to examine tissue including interpretation and report | Facility | 2023 | 82 | 116 | $8,584 | $1,048 | 12.2% |
| 85060 | Blood smear interpretation by physician with written report | Facility | 2023 | 37 | 45 | $4,725 | $815.33 | 17.3% |
| 88307 | Pathology examination of tissue using a microscope, moderately high complexity | Facility | 2023 | 12 | 12 | $4,380 | $771.00 | 17.6% |
| 88333 | Pathology cytologic examination of specimen during surgery, initial site | Facility | 2023 | 12 | 12 | $2,904 | $581.64 | 20.0% |
| 88341 | Special stained specimen slides to examine tissue, each additional procedure | Facility | 2022 | 99 | 559 | $50,310 | $12,481 | 24.8% |
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Facility | 2022 | 150 | 318 | $55,650 | $9,386 | 16.9% |
| 88360 | Microscopic genetic analysis of tumor, manual | Facility | 2022 | 120 | 263 | $59,175 | $8,571 | 14.5% |
| 85097 | Bone marrow, smear interpretation | Facility | 2022 | 130 | 142 | $40,896 | $5,402 | 13.2% |
| 88189 | Flow cytometry technique for dna or cell analysis, 16 or more markers | Facility | 2022 | 68 | 72 | $33,480 | $4,566 | 13.6% |
| 88342 | Special stained specimen slides to examine tissue, initial procedure | Facility | 2022 | 122 | 143 | $27,885 | $3,964 | 14.2% |
| 88365 | Genetic sequencing localization, initial procedure | Facility | 2022 | 76 | 84 | $22,680 | $2,911 | 12.8% |
| 88364 | Genetic sequencing localization, each additional procedure | Facility | 2022 | 56 | 64 | $9,600 | $1,741 | 18.1% |
| 88311 | Preparation of tissue for examination by removing any calcium present | Facility | 2022 | 132 | 143 | $7,865 | $1,397 | 17.8% |
| 85060 | Blood smear interpretation by physician with written report | Facility | 2022 | 59 | 66 | $6,930 | $1,278 | 18.4% |
| 88313 | Special stained specimen slides to examine tissue including interpretation and report | Facility | 2022 | 103 | 135 | $9,990 | $1,271 | 12.7% |
| 88307 | Pathology examination of tissue using a microscope, moderately high complexity | Facility | 2022 | 12 | 13 | $4,745 | $858.15 | 18.1% |
About Dr. Mingyi Chen, MD
Dr. Mingyi Chen, MD is a Hematology healthcare provider based in Dallas, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/10/2007. The National Provider Identifier (NPI) number assigned to this provider is 1861606303.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Mingyi Chen, MD has received a total of $49,569 in payments from pharmaceutical and medical device companies, with $12,668 received in 2024. These payments were reported across 80 transactions from 10 companies. The most common payment nature is "Consulting Fee" ($20,843).
As a Medicare-enrolled provider, Chen has provided services to 4,126 Medicare beneficiaries, totaling 7,306 services with total Medicare billing of $199,527. Data is available for 4 years (2020–2023), covering 53 distinct procedure/service records.
Ad
Practice Information
- Specialty Hematology
- Other Specialties Hematology & Oncology
- Location Dallas, TX
- Active Since 05/10/2007
- Last Updated 10/09/2025
- Taxonomy Code 207ZH0000X
- Entity Type Individual
- NPI Number 1861606303
Products in Payments
- Sylvant (Biological) $16,868
- SYLVANT (Drug) $12,668
- OPDIVO (Biological) $8,532
- Reblozyl (Drug) $5,490
- IMBRUVICA (Drug) $2,712
- Sylvant (Drug) $1,815
- MOZOBIL (Drug) $450.00
- GENEXPERT (Device) $315.00
- ELITEK (Drug) $120.00
- UNITUXIN (Drug) $100.00
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Hematology Doctors in Dallas
Dr. Steven Held, M.d, M.D
Hematology — Payments: $65,044
Hematology $65,044
Aimaz Afrough, M.d, M.D
Hematology — Payments: $13,347
Hematology $13,347
Ibrahim Ibrahim, M.d, M.D
Hematology — Payments: $1,868
Hematology $1,868
Mr. Jean-Antoine Ribeil, Md, Phd, MD, PHD
Hematology — Payments: $1,431
Hematology $1,431
Franklin Fuda, Do, DO
Hematology — Payments: $315.64
Hematology $315.64
Beth Wright, Md, MD
Hematology — Payments: $255.25
Hematology $255.25